Chronic inflammation of middle ear cholesteatoma promotes its recurrence via a paracrine mechanism

Schürmann M, Oppel F, Shao S, Volland-Thurn V, Kaltschmidt C, Kaltschmidt B, Scholtz L-U, Sudhoff H (2021)
Cell Communication and Signaling 19(1): 25.

Zeitschriftenaufsatz | Veröffentlicht | Englisch
 
Download
OA 3.55 MB
Autor*in
Schürmann, Matthias; Oppel, Felix; Shao, Senyao; Volland-Thurn, Verena; Kaltschmidt, ChristianUniBi; Kaltschmidt, BarbaraUniBi; Scholtz, Lars-Uwe; Sudhoff, HolgerUniBi
Abstract / Bemerkung
Background Cholesteatoma disease is an expanding lesion in the middle ear. Hearing loss and facial paralysis alongside with other intracranial complications are found. No pharmaceutical treatment is available today and recurrence after surgical extraction occurs. We investigated possible TLR4-based mechanisms promoting recurrence and explore possible treatments strategies. Methods We isolated fibroblasts and epidermal stem cells from cholesteatoma tissue and healthy auditory canal skin. Subsequently, their expression under standard culture conditions and after stimulation with LPS was investigated by RT-qPCR. Cell metabolism and proliferation were analysed upon LPS treatment, with and without TLR4 antagonist. An indirect co-culture of fibroblasts and epidermal stem cells isolated from cholesteatoma tissue was utilized to monitor epidermal differentiation upon LPS treatment by RT-qPCR and immunocytochemistry. Results Under standard culture conditions, we detected a tissue-independent higher expression of IL-1β and IL-8 in stem cells, an upregulation of KGF and IGF-2 in both cell types derived from cholesteatoma and higher expression of TLR4 in stem cells derived from cholesteatoma tissue. Upon LPS challenge, we could detect a significantly higher expression of IL-1α, IL-1β, IL-6 and IL-8 in stem cells and of TNF-a, GM-CSF and CXCL-5 in stem cells and fibroblasts derived from cholesteatoma. The expression of the growth factors KGF, EGF, EREG, IGF-2 and HGF was significantly higher in fibroblasts, particularly when derived from cholesteatoma. Upon treatment with LPS the metabolism was elevated in stem cells and fibroblasts, proliferation was only enhanced in fibroblasts derived from cholesteatoma. This could be reversed by the treatment with a TLR4 antagonist. The cholesteatoma fibroblasts could be triggered by LPS to promote the epidermal differentiation of the stem cells, while no LPS treatment or LPS treatment without the presence of fibroblasts did not result in such a differentiation. Conclusion We propose that cholesteatoma recurrence is based on TLR4 signalling imprinted in the cholesteatoma cells. It induces excessive inflammation of stem cells and fibroblasts, proliferation of perimatrix fibroblasts and the generation of epidermal cells from stem cells thru paracrine signalling by fibroblasts. Treatment of the operation site with a TLR4 antagonist might reduce the chance of cholesteatoma recurrence.
Erscheinungsjahr
2021
Zeitschriftentitel
Cell Communication and Signaling
Band
19
Ausgabe
1
Art.-Nr.
25
eISSN
1478-811X
Finanzierungs-Informationen
Open-Access-Publikationskosten wurden durch die Universität Bielefeld im Rahmen des DEAL-Vertrags gefördert.
Page URI
https://pub.uni-bielefeld.de/record/2951652

Zitieren

Schürmann M, Oppel F, Shao S, et al. Chronic inflammation of middle ear cholesteatoma promotes its recurrence via a paracrine mechanism. Cell Communication and Signaling. 2021;19(1): 25.
Schürmann, M., Oppel, F., Shao, S., Volland-Thurn, V., Kaltschmidt, C., Kaltschmidt, B., Scholtz, L. - U., et al. (2021). Chronic inflammation of middle ear cholesteatoma promotes its recurrence via a paracrine mechanism. Cell Communication and Signaling, 19(1), 25. https://doi.org/10.1186/s12964-020-00690-y
Schürmann, M., Oppel, F., Shao, S., Volland-Thurn, V., Kaltschmidt, C., Kaltschmidt, B., Scholtz, L. - U., and Sudhoff, H. (2021). Chronic inflammation of middle ear cholesteatoma promotes its recurrence via a paracrine mechanism. Cell Communication and Signaling 19:25.
Schürmann, M., et al., 2021. Chronic inflammation of middle ear cholesteatoma promotes its recurrence via a paracrine mechanism. Cell Communication and Signaling, 19(1): 25.
M. Schürmann, et al., “Chronic inflammation of middle ear cholesteatoma promotes its recurrence via a paracrine mechanism”, Cell Communication and Signaling, vol. 19, 2021, : 25.
Schürmann, M., Oppel, F., Shao, S., Volland-Thurn, V., Kaltschmidt, C., Kaltschmidt, B., Scholtz, L.-U., Sudhoff, H.: Chronic inflammation of middle ear cholesteatoma promotes its recurrence via a paracrine mechanism. Cell Communication and Signaling. 19, : 25 (2021).
Schürmann, Matthias, Oppel, Felix, Shao, Senyao, Volland-Thurn, Verena, Kaltschmidt, Christian, Kaltschmidt, Barbara, Scholtz, Lars-Uwe, and Sudhoff, Holger. “Chronic inflammation of middle ear cholesteatoma promotes its recurrence via a paracrine mechanism”. Cell Communication and Signaling 19.1 (2021): 25.
Alle Dateien verfügbar unter der/den folgenden Lizenz(en):
Creative Commons Namensnennung 4.0 International Public License (CC-BY 4.0):
Volltext(e)
Access Level
OA Open Access
Zuletzt Hochgeladen
2021-02-25T07:45:36Z
MD5 Prüfsumme
8f1184c71ef86442fbc80588d410cbe2

Export

Markieren/ Markierung löschen
Markierte Publikationen

Open Data PUB

Web of Science

Dieser Datensatz im Web of Science®

Quellen

PMID: 33627146
PubMed | Europe PMC

Suchen in

Google Scholar